262 related articles for article (PubMed ID: 11761835)
1. [Chronic hepatitis C and risk for hepatitis A infection].
Chlabicz S; Grzeszczuk A
Przegl Epidemiol; 2001; 55(3):281-6. PubMed ID: 11761835
[TBL] [Abstract][Full Text] [Related]
2. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
[TBL] [Abstract][Full Text] [Related]
4. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
5. [Risks associated with hepatitis infection in patients with hepatitis C and opportunities for prophylaxis].
Chlabicz S
Przegl Epidemiol; 2003; 57(3):465-70. PubMed ID: 14682165
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis A virus antibodies in patients with chronic liver diseases.
López Serrano A; Antón Conejero MD; Alcaraz Soriano MJ; García del Castillo G; Gómez Pajares F; Moreno-Osset E
Rev Esp Enferm Dig; 2000 Aug; 92(8):508-17. PubMed ID: 11084818
[TBL] [Abstract][Full Text] [Related]
8. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
9. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
Bryan JP; Nelson M
Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
Wong KH; Liu YM; Ng PS; Young BW; Lee SS
J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
[TBL] [Abstract][Full Text] [Related]
11. [HAV infection in patients with chronic hepatitis C].
Bertino G; Ardiri AM; Bruno MC; Valenti M; Lerna D; Boemi PM; Interlandi D; Urso G; Fisichella A; Pulvirenti D; Neri S
Clin Ter; 2007; 158(3):223-5. PubMed ID: 17612281
[TBL] [Abstract][Full Text] [Related]
12. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
Myers RP; Gregor JC; Marotta PJ
Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
[TBL] [Abstract][Full Text] [Related]
14. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
16. Occupational risk of hepatitis A infection among health care providers in northeastern Poland.
Grzeszczuk A; Sokolewicz-Bobrowska E; Chlabicz S
Med Sci Monit; 2003 Jul; 9(7):PH11-4. PubMed ID: 12883461
[TBL] [Abstract][Full Text] [Related]
17. [Studies on re-immunization with live attenuated hepatitis A vaccine].
Liu Y; Xu Z; Ouyang P
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):162-4. PubMed ID: 10322791
[TBL] [Abstract][Full Text] [Related]
18. A seroepidemiologic study of Helicobacter pylori and hepatitis A virus infection in primary school students in Taipei.
Lin HY; Chuang CK; Lee HC; Chiu NC; Lin SP; Yeung CY
J Microbiol Immunol Infect; 2005 Jun; 38(3):176-82. PubMed ID: 15986067
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of previous hepatitis A virus infection in renal transplant patients with hepatitis C: evidence of persistent anti-hepatitis A virus immune response.
Mariya FA; de Mello Perez R; Silva AE; Pestana JO; Ferraz ML
Transplant Proc; 2004 Jun; 36(5):1500-1. PubMed ID: 15251370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
